Mentari Therapeutics, Inc. (MTRI)
14.48
-0.76
(-5.02%)
USD |
NASDAQ |
Nov 20, 10:47
Mentari Therapeutics Free Cash Flow : -7.839M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -7.839M |
| June 30, 2026 | -8.628M |
| March 31, 2026 | -8.040M |
| December 31, 2025 | -7.843M |
| September 30, 2025 | -8.263M |
| June 30, 2025 | -8.159M |
| March 31, 2025 | -6.800M |
| December 31, 2024 | -7.202M |
| September 30, 2024 | -6.580M |
| June 30, 2024 | -6.928M |
| March 31, 2024 | -6.861M |
| December 31, 2023 | -6.552M |
| September 30, 2023 | -7.343M |
| June 30, 2023 | -7.424M |
| March 31, 2023 | -10.52M |
| December 31, 2022 | -14.14M |
| September 30, 2022 | -15.09M |
| June 30, 2022 | -15.49M |
| March 31, 2022 | -13.70M |
| December 31, 2021 | -14.02M |
| September 30, 2021 | -11.51M |
| June 30, 2021 | -10.23M |
| March 31, 2021 | -9.275M |
| December 31, 2020 | -5.157M |
| September 30, 2020 | -6.162M |
| Date | Value |
|---|---|
| June 30, 2020 | -7.188M |
| March 31, 2020 | -7.727M |
| December 31, 2019 | -8.328M |
| September 30, 2019 | -7.658M |
| June 30, 2019 | -6.580M |
| March 31, 2019 | -5.804M |
| December 31, 2018 | -4.486M |
| September 30, 2018 | -3.902M |
| June 30, 2018 | -3.662M |
| March 31, 2018 | -3.400M |
| December 31, 2017 | -3.391M |
| September 30, 2017 | -3.220M |
| June 30, 2017 | -2.308M |
| March 31, 2017 | -1.651M |
| December 31, 2016 | -0.9577M |
| September 30, 2016 | -0.4229M |
| June 30, 2016 | -0.3883M |
| March 31, 2016 | -1.056M |
| December 31, 2015 | -1.668M |
| September 30, 2015 | -1.647M |
| June 30, 2015 | -1.621M |
| March 31, 2015 | -1.491M |
| December 31, 2014 | -0.8175M |
| September 30, 2014 | -0.7318M |
| June 30, 2014 | -0.6293M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Liquidia Corp. | 291.15M |
| Johnson & Johnson | 19.98B |
| Eli Lilly & Co. | 11.69B |
| Merck & Co., Inc. | 14.75B |
| ANI Pharmaceuticals, Inc. | 199.91M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.142M |
| Cash from Investing (Quarterly) | 0.0024M |
| Cash from Financing (Quarterly) | 0.04M |
| Free Cash Flow Per Share (Quarterly) | -0.2089 |
| Free Cash Flow to Equity (Quarterly) | -1.142M |
| Free Cash Flow to Firm (Quarterly) | -1.142M |
| Free Cash Flow Yield | -9.85% |